Digital pathology for repeat prostate biopsy reassessment during active surveillance: an institutional experience
Archivio Italiano di Urologia e Andrologia · 15.06.2026 · 98 (2)
DOI: 10.4081/aiua.2026.15596 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archivio Italiano di Urologia e Andrologia, online erschienen am 15.06.2026. Verfasst von Ludovica Pepe und 3 weiteren Autor:innen. Beteiligte Einrichtung: Anatomic Pathology Unit, Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina; PhD Program in Transl…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Watchful Waiting, Prostate. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Repeat biopsy remains central to active surveillance (AS) because upgrading and tumor burden may change management.
Methods
This retrospective paired workflow study included 38 men and 47 repeat biopsy sessions (2023-2025), comprising 846 biopsy cores and 871 H&E slides. Whole-slide imaging (WSI) and conventional microscopy were compared after a washout interval. QuPath was used only for pathologist-guided tumorlength and greatest percentage of cancer (GPC) documentation.
Results
On the first eligible repeat biopsy, upgrading to ISUP Grade Group (GG) 2 occurred in 7/38 men (18.4%; 95% CI, 7.7- 34.3). No GG3, cribriform morphology, or intraductal carcinoma was identified. Protocol-linked reclassification occurred in 11/38 men (28.9%). Slide-level cancer-detection agreement was 856/871 (98.3%; kappa = 0.91), and raw patient-level agreement for upgrading was 36/38 (94.7%; kappa = 0.80). After adjudication, no upgraded patient remained missed. QuPathsupported measurement was interpretable in 79/101 positive core-level assessments (78.2%), with excellent agreement (ICC = 0.98) and shorter median measurement time (41 s vs 78 s).
Conclusions
WSI reproduced management-relevant conventional microscopy outputs in repeat AS biopsies. Its value was organizational and documentary, not autonomous cancer detection or grading.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Anatomic Pathology Unit, Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina; PhD Program in Translational Molecular Medicine and Surgery, Department of Biomedical Scien…
- Pathology Unit, Cannizzaro Hospital, Catania.
- Urology Unit, Cannizzaro Hospital, Catania.
Zitieren
APA
Pepe, L., Curduman, M., Pepe, P., & Fiorentino, V. (2026). Digital pathology for repeat prostate biopsy reassessment during active surveillance: an institutional experience. Archivio Italiano di Urologia e Andrologia, 98(2). https://doi.org/10.4081/aiua.2026.15596
Vancouver
Pepe L, Curduman M, Pepe P, Fiorentino V. Digital pathology for repeat prostate biopsy reassessment during active surveillance: an institutional experience. Archivio Italiano di Urologia e Andrologia. 2026;98(2). doi:10.4081/aiua.2026.15596
BibTeX
@article{Pepe2026,
author = {Pepe, Ludovica and Curduman, Mara and Pepe, Pietro and Fiorentino, Vincenzo},
title = {Digital pathology for repeat prostate biopsy reassessment during active surveillance: an institutional experience},
journal = {Archivio Italiano di Urologia e Andrologia},
year = {2026},
volume = {98},
number = {2},
doi = {10.4081/aiua.2026.15596}
}
EUVIMED